शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSECian Healthcare Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 3 Sept, 2025 · 19:35 IST

In continuation to our earlier intimation dated July 01, 2025 with respect to the approval of Resolution Plan by the Committee of Creditors and its subsequent submission before the Hon''ble ....

NCLT admitted insolvencyRegulatory & Legal View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Cian Healthcare Limited, currently under the Corporate Insolvency Resolution Process (CIRP), informed BSE that its resolution plan was heard before the NCLT Mumbai Bench-VI on September 3, 2025. Earlier, the Committee of Creditors had approved the resolution plan on May 9, 2025, and it was submitted to the NCLT on May 23, 2025. The next hearing for consideration and approval of the resolution plan is scheduled for October 7, 2025. Roshen Chordiya continues to act as the Resolution Professional.

Likely market impact

The company's fate still hangs in the balance as NCLT approval of the resolution plan is pending. Shareholders should watch the October 7, 2025 hearing closely, as approval could lead to the company's revival and potential recovery in share value, while rejection may prolong the insolvency process and increase uncertainty.